Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

BACKGROUND: In a previously reported study, patients with regionally advanced melanoma were treated with neoadjuvant ipilimumab (ipi) (Tarhini in PLoS ONE 9(2): e87705, 3). Significant changes in circulating myeloid derived suppressor cells (MDSC), regulatory T cells (Treg) and peptide specific type...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Transl Med
Auteurs principaux: Najjar, Yana G., Ding, Fei, Lin, Yan, VanderWeele, Robert, Butterfield, Lisa H., Tarhini, Ahmad A.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5319167/
https://ncbi.nlm.nih.gov/pubmed/28222797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-017-1140-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires